Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...

The Centers for Medicare & Medicaid Services (CMS) said newly negotiated lower prices for 15 drugs will save 44%, or $12 ...

On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy of the policy.

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.